Generating Protective Immune Responses to Highly Mutable Viruses Twitter: @conservbiosci
ConserV Bioscience is a forward-thinking biotechnology company dedicated to developing innovative vaccines that provide robust protection against a wide array of infectious diseases. Focused on both endemic and emergent threats, ConserV Bioscience employs cutting-edge research and development to create safe and effective solutions for global health challenges. Located at 77 Heyford Park, Bicester, OX25 5HD, GB, ConserV Bioscience is committed to pioneering advancements in vaccine technology.
With a robust pipeline of vaccines in various stages of development, ConserV Bioscience addresses critical areas such as broad-spectrum influenza, broad-spectrum coronavirus, and mosquito-borne diseases. The company’s unique approach involves identifying antigens from conserved regions of viral proteins, ensuring a high number of REACTIVE T-cell epitopes with extensive HLA coverage. This strategy allows ConserV Bioscience to create vaccines that offer broad protection against evolving viral strains.
ConserV Bioscience is dedicated to scientific excellence and collaborative partnerships, striving to make a significant impact on global healthcare. The company's focus on innovation and commitment to addressing unmet medical needs positions ConserV Bioscience as a leader in the biotechnology sector. We invite the management team at ConserV Bioscience to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.
Compare ConserV Bioscience with 3 companies in Biotechnology
| Comparison Field |
ConserV BioscienceMain Company |
Alomone LabsView Profile |
Radiopharm Theranost...View Profile |
OxitecView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1989 | 2021 | 2002 |
|
Company Size
|
— | 11-50 | 2-10 | 51-200 |
|
City
|
Oxford, Oxfordshire | |||
|
Country
|
United Kingdom | |||
|
Skills & Keywords
Comparing with main company
|
28 Total Skills
Vaccine Development
Infectious Diseases
Biotechnology
Viral Antigens
Immunology
Healthcare Solutions
Pharmaceutical Research
vaccine
mosquito
zika
antigen
malaria
MHC Class I
HIV
collaboration
peptides
adjuvant
antibodies
Chagas
broad-spectrum
influenza
coronavirus
RSV
mRNA
hepatitis
ratovirus
MHC Class II
denge
|
6 Total
6 Unique
Unique Skills:
ion channels
live cell imaging
research reagents
Tools for Ion Channel Research
toxins
venom toxins
|
25 Total
25 Unique
Unique Skills:
biotech
biotechnology
braincancer
breastcancer
breastcancerimaging
cancer
+19
|
9 Total
9 Unique
Unique Skills:
agriculture
dengue
Genetic modification
mosquito control
Pest Control
Pesticide resistance management
+3
|
Other organizations in the same industry
This company is also known as